Clinical Trial Update: PK/PD Study of Netupitant and Palonosetron in Pediatric Patients for Prevention of Chemotherapy-induced Nausea and Vomiting [Phase 2]

View source ↗

Summary

Phase 2 PK/PD study in pediatric patients evaluating netupitant and palonosetron for prevention of chemotherapy-induced nausea and vomiting; study completed wit…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chemotherapy-induced Nausea and Vomiting

Drugs mentioned

• Netupitant (netupitant)
• Palonosetron (palonosetron)

Snippet

Sponsor: Helsinn Healthcare SA | Conditions: Chemotherapy-induced Nausea and Vomiting (CINV) | Phase 2 | Status: COMPLETED | Results posted: 2020-12-07